Neuropsychiatric symptoms · depression and anxiety for people with dementia and MCI
It is very uncertain whether CBT treatments changes neuropsychiatric symptoms post‐treatment compared with treatment (very low certainty).
1 finding from 1 review
Depression score · co‐occurring depression and substance use disorders
2 findings from 1 review
Percent of days abstinent · co‐occurring depression and substance use disorders
2 findings from 1 review
Retention in treatment · co‐occurring depression and substance use disorders
It is very uncertain whether integrated CBT changes treatment retention compared with twelve Step Facilitation (very low certainty).
1 finding from 1 review
Number of treatment sessions attended Scale from: 0 to 36 · co‐occurring depression and substance use disorders
1 finding from 1 review
Clinical non‐response at post‐treatment · depression
It is very uncertain whether third wave CBT changes clinical non‐response at post‐treatment compared with TAU (very low certainty).
1 finding from 1 review
Acceptability (number of participants lost to post‐treatment assessment) · depression
It is very uncertain whether third wave CBT changes treatment acceptability (dropout) at post‐treatment compared with TAU (very low certainty).
1 finding from 1 review
Clinical non‐remission at post‐treatment · depression
It is very uncertain whether third wave CBT changes clinical non‐remission at post‐treatment compared with TAU (very low certainty).
1 finding from 1 review
Depression levels at post‐treatment · depression
1 finding from 1 review
Anxiety · depression
1 finding from 1 review
Social adjustment levels at post‐treatment— behavioural activation vs TAU Work and Social Ajustment Scale (WSAS) · depression
1 finding from 1 review
Leaving the study early · Adults with PTSD for at least 3 months
1 finding from 1 review
Successful discontinuation of BZDs‐ post treatment Objective and subjective · patients with BZD harmful use, abuse or dependence
CBT (plus taper) probably leads to higher successful discontinuation of BZDs‐ post treatment Objective and… compared with taper (moderate certainty).
1 finding from 1 review
Successful discontinuation of BZDs‐ 12 month · patients with BZD harmful use, abuse or dependence
CBT (plus taper) showed no clear difference in successful discontinuation of BZDs‐ 12 month compared with taper (moderate certainty).
1 finding from 1 review
Reduce BZDs> 50% ‐ post treatment Objective · patients with BZD harmful use, abuse or dependence
CBT (plus taper) showed no clear difference in reduce BZDs> 50% ‐ post treatment Objective compared with taper (low certainty).
1 finding from 1 review
Reduce BZDs> 50% ‐ 12 month · patients with BZD harmful use, abuse or dependence
CBT (plus taper) showed no clear difference in reduce BZDs> 50% ‐ 12 month compared with taper (low certainty).
1 finding from 1 review
Severity of PTSD symptoms · Adults with co‐morbid PTSD and SMI
1 finding from 1 review
Severity of PTSD symptoms · Adults with co‐morbid PTSD and SMI
1 finding from 1 review
Quality of life: 1. General quality of life · Adults with co‐morbid PTSD and SMI
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Symptoms of co‐morbid psychosis: 1. Overall mental state · Adults with co‐morbid PTSD and SMI
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found